SCIENTIFIC PROGRAMME
SESSION I
BIOLOGY OF B-CELL
PRECURSOR ALL
SESSION II
BIOLOGY OF T-CELL ALL
SESSION III
MINIMAL RESIDUAL
DISEASE MONITORING
SESSION IV
INDIVIDUALIZED
MANAGEMENT OF ALL
SESSION V
NEW ADVANCES IN ALL
SESSION VI
CAR T-CELLS &
ALLOGENEIC HSCT
SESSION VII
FRONTLINE
INCORPORATION OF
BITES AND ADCS
SESSION VIII
T-CELL ALL AND
LYMPHOBLASTIC
LYMPHOMA
SESSION IX
PH AND PH-LIKE ALL
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
AS E-POSTERS
DISCLOSURES
LIVE Programme CEST time
16:05-16:20 Which TKI-Chemo-Transplant Cocktail for Ph+ ALL? Yves Chalandon (Geneva)
16:20-16:35 Next generation TKIs for Ph+ ALL Nicholas Short (Houston)
16:35-16:50 Ph-like ALL Patient Management Sarah Tasian (Philadelphia)
BRIEF ORAL COMMUNICATION:
16:50-17:00 IL7R Gain-of-Function Mutation Is Sufficient to Initiate Afonso R.M. Almeida (Lisboa)
B-Cell Acute Lymphoblastic Leukemia In Vivo with Features
of PAX5 P80R and Ph-like ALL
17:00-17:30 Panel discussion
17:30-17:45 Closing Remarks: The 4 Chairpersons
5